001     274170
005     20240918105640.0
024 7 _ |a 10.1016/j.ajhg.2023.02.003
|2 doi
024 7 _ |a pmid:36827971
|2 pmid
024 7 _ |a 0002-9297
|2 ISSN
024 7 _ |a 1537-6605
|2 ISSN
024 7 _ |a altmetric:142844520
|2 altmetric
037 _ _ |a DKFZ-2023-00472
041 _ _ |a English
082 _ _ |a 570
100 1 _ |a Morra, Anna
|b 0
245 _ _ |a The impact of coding germline variants on contralateral breast cancer risk and survival.
260 _ _ |a New York, NY
|c 2023
|b Elsevier
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1726649777_14745
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Evidence linking coding germline variants in breast cancer (BC)-susceptibility genes other than BRCA1, BRCA2, and CHEK2 with contralateral breast cancer (CBC) risk and breast cancer-specific survival (BCSS) is scarce. The aim of this study was to assess the association of protein-truncating variants (PTVs) and rare missense variants (MSVs) in nine known (ATM, BARD1, BRCA1, BRCA2, CHEK2, PALB2, RAD51C, RAD51D, and TP53) and 25 suspected BC-susceptibility genes with CBC risk and BCSS. Hazard ratios (HRs) and 95% confidence intervals (CIs) were estimated with Cox regression models. Analyses included 34,401 women of European ancestry diagnosed with BC, including 676 CBCs and 3,449 BC deaths; the median follow-up was 10.9 years. Subtype analyses were based on estrogen receptor (ER) status of the first BC. Combined PTVs and pathogenic/likely pathogenic MSVs in BRCA1, BRCA2, and TP53 and PTVs in CHEK2 and PALB2 were associated with increased CBC risk [HRs (95% CIs): 2.88 (1.70-4.87), 2.31 (1.39-3.85), 8.29 (2.53-27.21), 2.25 (1.55-3.27), and 2.67 (1.33-5.35), respectively]. The strongest evidence of association with BCSS was for PTVs and pathogenic/likely pathogenic MSVs in BRCA2 (ER-positive BC) and TP53 and PTVs in CHEK2 [HRs (95% CIs): 1.53 (1.13-2.07), 2.08 (0.95-4.57), and 1.39 (1.13-1.72), respectively, after adjusting for tumor characteristics and treatment]. HRs were essentially unchanged when censoring for CBC, suggesting that these associations are not completely explained by increased CBC risk, tumor characteristics, or treatment. There was limited evidence of associations of PTVs and/or rare MSVs with CBC risk or BCSS for the 25 suspected BC genes. The CBC findings are relevant to treatment decisions, follow-up, and screening after BC diagnosis.
536 _ _ |a 312 - Funktionelle und strukturelle Genomforschung (POF4-312)
|0 G:(DE-HGF)POF4-312
|c POF4-312
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
650 _ 7 |a breast cancer susceptibility genes
|2 Other
650 _ 7 |a coding germline variants
|2 Other
650 _ 7 |a contralateral breast cancer risk
|2 Other
650 _ 7 |a survival
|2 Other
650 _ 2 |a Female
|2 MeSH
650 _ 2 |a Humans
|2 MeSH
650 _ 2 |a Breast Neoplasms: genetics
|2 MeSH
650 _ 2 |a Genes, BRCA2
|2 MeSH
650 _ 2 |a Germ-Line Mutation
|2 MeSH
650 _ 2 |a Germ Cells
|2 MeSH
650 _ 2 |a Genetic Predisposition to Disease
|2 MeSH
700 1 _ |a Mavaddat, Nasim
|b 1
700 1 _ |a Muranen, Taru A
|b 2
700 1 _ |a Ahearn, Thomas U
|b 3
700 1 _ |a Allen, Jamie
|b 4
700 1 _ |a Andrulis, Irene L
|b 5
700 1 _ |a Auvinen, Päivi
|b 6
700 1 _ |a Becher, Heiko
|b 7
700 1 _ |a Behrens, Sabine
|0 P:(DE-He78)6b04712f3afe72044d496a25505cb1ea
|b 8
|u dkfz
700 1 _ |a Blomqvist, Carl
|b 9
700 1 _ |a Bojesen, Stig E
|b 10
700 1 _ |a Bolla, Manjeet K
|b 11
700 1 _ |a Brauch, Hiltrud
|0 P:(DE-HGF)0
|b 12
700 1 _ |a Camp, Nicola J
|b 13
700 1 _ |a Carvalho, Sara
|b 14
700 1 _ |a Castelao, Jose E
|b 15
700 1 _ |a Cessna, Melissa H
|b 16
700 1 _ |a Chang-Claude, Jenny
|0 P:(DE-He78)c259d6cc99edf5c7bc7ce22c7f87c253
|b 17
|u dkfz
700 1 _ |a Chenevix-Trench, Georgia
|b 18
700 1 _ |a NBCS Collaborators
|b 19
|e Collaboration Author
700 1 _ |a Czene, Kamila
|b 20
700 1 _ |a Decker, Brennan
|b 21
700 1 _ |a Dennis, Joe
|b 22
700 1 _ |a Dörk, Thilo
|b 23
700 1 _ |a Dorling, Leila
|b 24
700 1 _ |a Dunning, Alison M
|b 25
700 1 _ |a Ekici, Arif B
|b 26
700 1 _ |a Eriksson, Mikael
|b 27
700 1 _ |a Evans, D Gareth
|b 28
700 1 _ |a Fasching, Peter A
|b 29
700 1 _ |a Figueroa, Jonine D
|b 30
700 1 _ |a Flyger, Henrik
|b 31
700 1 _ |a Gago-Dominguez, Manuela
|b 32
700 1 _ |a García-Closas, Montserrat
|b 33
700 1 _ |a Geurts-Giele, Willemina R R
|b 34
700 1 _ |a Giles, Graham G
|b 35
700 1 _ |a Guénel, Pascal
|b 36
700 1 _ |a Gündert, Melanie
|0 P:(DE-HGF)0
|b 37
700 1 _ |a Hahnen, Eric
|b 38
700 1 _ |a Hall, Per
|b 39
700 1 _ |a Hamann, Ute
|0 P:(DE-He78)537e07b3e57b16c7b214fc2242e4326b
|b 40
|u dkfz
700 1 _ |a Harrington, Patricia A
|b 41
700 1 _ |a He, Wei
|b 42
700 1 _ |a Heikkilä, Päivi
|b 43
700 1 _ |a Hooning, Maartje J
|b 44
700 1 _ |a Hoppe, Reiner
|b 45
700 1 _ |a Howell, Anthony
|b 46
700 1 _ |a Humphreys, Keith
|b 47
700 1 _ |a Investigators, kConFab
|b 48
|e Collaboration Author
700 1 _ |a Jakubowska, Anna
|b 49
700 1 _ |a Jung, Audrey Ying-Chee
|0 P:(DE-He78)bce1fdec5ce564e2666156d96aeabec9
|b 50
|u dkfz
700 1 _ |a Keeman, Renske
|b 51
700 1 _ |a Kristensen, Vessela N
|b 52
700 1 _ |a Lubiński, Jan
|b 53
700 1 _ |a Mannermaa, Arto
|b 54
700 1 _ |a Manoochehri, Mehdi
|0 P:(DE-He78)16b8745cffb0db0d366978d3afe17ebc
|b 55
700 1 _ |a Manoukian, Siranoush
|b 56
700 1 _ |a Margolin, Sara
|b 57
700 1 _ |a Mavroudis, Dimitrios
|b 58
700 1 _ |a Milne, Roger L
|b 59
700 1 _ |a Mulligan, Anna Marie
|b 60
700 1 _ |a Newman, William G
|b 61
700 1 _ |a Park-Simon, Tjoung-Won
|b 62
700 1 _ |a Peterlongo, Paolo
|b 63
700 1 _ |a Pharoah, Paul D P
|b 64
700 1 _ |a Rhenius, Valerie
|b 65
700 1 _ |a Saloustros, Emmanouil
|b 66
700 1 _ |a Sawyer, Elinor J
|b 67
700 1 _ |a Schmutzler, Rita K
|b 68
700 1 _ |a Shah, Mitul
|b 69
700 1 _ |a Spurdle, Amanda B
|b 70
700 1 _ |a Tomlinson, Ian
|b 71
700 1 _ |a Truong, Thérèse
|b 72
700 1 _ |a van Veen, Elke M
|b 73
700 1 _ |a Vreeswijk, Maaike P G
|b 74
700 1 _ |a Wang, Qin
|b 75
700 1 _ |a Wendt, Camilla
|b 76
700 1 _ |a Yang, Xiaohong R
|b 77
700 1 _ |a Nevanlinna, Heli
|b 78
700 1 _ |a Devilee, Peter
|b 79
700 1 _ |a Easton, Douglas F
|b 80
700 1 _ |a Schmidt, Marjanka K
|b 81
700 1 _ |a Sahlberg, Kristine K
|b 82
|e Contributor
700 1 _ |a Børresen-Dale, Anne-Lise
|b 83
|e Contributor
700 1 _ |a Gram, Inger Torhild
|b 84
|e Contributor
700 1 _ |a Olsen, Karina Standahl
|b 85
|e Contributor
700 1 _ |a Engebråten, Olav
|b 86
|e Contributor
700 1 _ |a Naume, Bjørn
|b 87
|e Contributor
700 1 _ |a Geisler, Jürgen
|b 88
|e Contributor
700 1 _ |a Osbreac
|b 89
|e Contributor
700 1 _ |a Grenaker Alnæs, Grethe I
|b 90
|e Contributor
700 1 _ |a Amor, David
|b 91
|e Contributor
700 1 _ |a Andrews, Lesley
|b 92
|e Contributor
700 1 _ |a Antill, Yoland
|b 93
|e Contributor
700 1 _ |a Balleine, Rosemary
|b 94
|e Contributor
700 1 _ |a Beesley, Jonathan
|b 95
|e Contributor
700 1 _ |a Bennett, Ian
|b 96
|e Contributor
700 1 _ |a Bogwitz, Michael
|b 97
|e Contributor
700 1 _ |a Botes, Leon
|b 98
|e Contributor
700 1 _ |a Brennan, Meagan
|b 99
|e Contributor
700 1 _ |a Brown, Melissa
|b 100
|e Contributor
700 1 _ |a Buckley, Michael
|b 101
|e Contributor
700 1 _ |a Burke, Jo
|b 102
|e Contributor
700 1 _ |a Butow, Phyllis
|b 103
|e Contributor
700 1 _ |a Caldon, Liz
|b 104
|e Contributor
700 1 _ |a Campbell, Ian
|b 105
|e Contributor
700 1 _ |a Cao, Michelle
|b 106
|e Contributor
700 1 _ |a Chakrabarti, Anannya
|b 107
|e Contributor
700 1 _ |a Chauhan, Deepa
|b 108
|e Contributor
700 1 _ |a Chauhan, Manisha
|b 109
|e Contributor
700 1 _ |a Chenevix-Trench, Georgia
|b 110
|e Contributor
700 1 _ |a Christian, Alice
|b 111
|e Contributor
700 1 _ |a Cohen, Paul
|b 112
|e Contributor
700 1 _ |a Colley, Alison
|b 113
|e Contributor
700 1 _ |a Crook, Ashley
|b 114
|e Contributor
700 1 _ |a Cui, James
|b 115
|e Contributor
700 1 _ |a Courtney, Eliza
|b 116
|e Contributor
700 1 _ |a Cummings, Margaret
|b 117
|e Contributor
700 1 _ |a Dawson, Sarah-Jane
|b 118
|e Contributor
700 1 _ |a DeFazio, Anna
|b 119
|e Contributor
700 1 _ |a Delatycki, Martin
|b 120
|e Contributor
700 1 _ |a Dickson, Rebecca
|b 121
|e Contributor
700 1 _ |a Dixon, Joanne
|b 122
|e Contributor
700 1 _ |a Edkins, Ted
|b 123
|e Contributor
700 1 _ |a Edwards, Stacey
|b 124
|e Contributor
700 1 _ |a Farshid, Gelareh
|b 125
|e Contributor
700 1 _ |a Fellows, Andrew
|b 126
|e Contributor
700 1 _ |a Fenton, Georgina
|b 127
|e Contributor
700 1 _ |a Field, Michael
|b 128
|e Contributor
700 1 _ |a Flanagan, James
|b 129
|e Contributor
700 1 _ |a Fong, Peter
|b 130
|e Contributor
700 1 _ |a Forrest, Laura
|b 131
|e Contributor
700 1 _ |a Fox, Stephen
|b 132
|e Contributor
700 1 _ |a French, Juliet
|b 133
|e Contributor
700 1 _ |a Friedlander, Michael
|b 134
|e Contributor
700 1 _ |a Gaff, Clara
|b 135
|e Contributor
700 1 _ |a Gattas, Mike
|b 136
|e Contributor
700 1 _ |a George, Peter
|b 137
|e Contributor
700 1 _ |a Greening, Sian
|b 138
|e Contributor
700 1 _ |a Harris, Marion
|b 139
|e Contributor
700 1 _ |a Hart, Stewart
|b 140
|e Contributor
700 1 _ |a Hayward, Nick
|b 141
|e Contributor
700 1 _ |a Hopper, John
|b 142
|e Contributor
700 1 _ |a Hoskins, Cass
|b 143
|e Contributor
700 1 _ |a Hunt, Clare
|b 144
|e Contributor
700 1 _ |a James, Paul
|b 145
|e Contributor
700 1 _ |a Jenkins, Mark
|b 146
|e Contributor
700 1 _ |a Kidd, Alexa
|b 147
|e Contributor
700 1 _ |a Kirk, Judy
|b 148
|e Contributor
700 1 _ |a Koehler, Jessica
|b 149
|e Contributor
700 1 _ |a Kollias, James
|b 150
|e Contributor
700 1 _ |a Lakhani, Sunil
|b 151
|e Contributor
700 1 _ |a Lawrence, Mitchell
|b 152
|e Contributor
700 1 _ |a Lee, Jason
|b 153
|e Contributor
700 1 _ |a Li, Shuai
|b 154
|e Contributor
700 1 _ |a Lindeman, Geoff
|b 155
|e Contributor
700 1 _ |a Lipton, Lara
|b 156
|e Contributor
700 1 _ |a Lobb, Liz
|b 157
|e Contributor
700 1 _ |a Loi, Sherene
|b 158
|e Contributor
700 1 _ |a Mann, Graham
|b 159
|e Contributor
700 1 _ |a Marsh, Deborah
|b 160
|e Contributor
700 1 _ |a McLachlan, Sue Anne
|b 161
|e Contributor
700 1 _ |a Meiser, Bettina
|b 162
|e Contributor
700 1 _ |a Milne, Roger
|b 163
|e Contributor
700 1 _ |a Nightingale, Sophie
|b 164
|e Contributor
700 1 _ |a O'Connell, Shona
|b 165
|e Contributor
700 1 _ |a O'Sullivan, Sarah
|b 166
|e Contributor
700 1 _ |a Ortega, David Gallego
|b 167
|e Contributor
700 1 _ |a Pachter, Nick
|b 168
|e Contributor
700 1 _ |a Pang, Jia-Min
|b 169
|e Contributor
700 1 _ |a Pathak, Gargi
|b 170
|e Contributor
700 1 _ |a Patterson, Briony
|b 171
|e Contributor
700 1 _ |a Pearn, Amy
|b 172
|e Contributor
700 1 _ |a Phillips, Kelly
|b 173
|e Contributor
700 1 _ |a Pieper, Ellen
|b 174
|e Contributor
700 1 _ |a Ramus, Susan
|b 175
|e Contributor
700 1 _ |a Rickard, Edwina
|b 176
|e Contributor
700 1 _ |a Robinson, Bridget
|b 177
|e Contributor
700 1 _ |a Saleh, Mona
|b 178
|e Contributor
700 1 _ |a Skandarajah, Anita
|b 179
|e Contributor
700 1 _ |a Salisbury, Elizabeth
|b 180
|e Contributor
700 1 _ |a Saunders, Christobel
|b 181
|e Contributor
700 1 _ |a Saunus, Jodi
|b 182
|e Contributor
700 1 _ |a Scott, Rodney
|b 183
|e Contributor
700 1 _ |a Scott, Clare
|b 184
|e Contributor
700 1 _ |a Sexton, Adrienne
|b 185
|e Contributor
700 1 _ |a Shelling, Andrew
|b 186
|e Contributor
700 1 _ |a Simpson, Peter
|b 187
|e Contributor
700 1 _ |a Southey, Melissa
|b 188
|e Contributor
700 1 _ |a Spurdle, Amanda
|b 189
|e Contributor
700 1 _ |a Taylor, Jessica
|b 190
|e Contributor
700 1 _ |a Taylor, Renea
|b 191
|e Contributor
700 1 _ |a Thorne, Heather
|b 192
|e Contributor
700 1 _ |a Trainer, Alison
|b 193
|e Contributor
700 1 _ |a Tucker, Kathy
|b 194
|e Contributor
700 1 _ |a Visvader, Jane
|b 195
|e Contributor
700 1 _ |a Walker, Logan
|b 196
|e Contributor
700 1 _ |a Williams, Rachael
|b 197
|e Contributor
700 1 _ |a Winship, Ingrid
|b 198
|e Contributor
700 1 _ |a Young, Mary Ann
|b 199
|e Contributor
700 1 _ |a Zaheed, Milita
|b 200
|e Contributor
773 _ _ |a 10.1016/j.ajhg.2023.02.003
|g Vol. 110, no. 3, p. 475 - 486
|0 PERI:(DE-600)1473813-2
|n 3
|p 475 - 486
|t The American journal of human genetics
|v 110
|y 2023
|x 0002-9297
909 C O |p VDB
|o oai:inrepo02.dkfz.de:274170
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 8
|6 P:(DE-He78)6b04712f3afe72044d496a25505cb1ea
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 12
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 17
|6 P:(DE-He78)c259d6cc99edf5c7bc7ce22c7f87c253
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 37
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 40
|6 P:(DE-He78)537e07b3e57b16c7b214fc2242e4326b
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 50
|6 P:(DE-He78)bce1fdec5ce564e2666156d96aeabec9
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 55
|6 P:(DE-He78)16b8745cffb0db0d366978d3afe17ebc
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-312
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Funktionelle und strukturelle Genomforschung
|x 0
914 1 _ |y 2023
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2022-11-11
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2022-11-11
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2022-11-11
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b AM J HUM GENET : 2022
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0320
|2 StatID
|b PubMed Central
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2023-10-21
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2023-10-21
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b AM J HUM GENET : 2022
|d 2023-10-21
920 1 _ |0 I:(DE-He78)C020-20160331
|k C020
|l C020 Epidemiologie von Krebs
|x 0
920 1 _ |0 I:(DE-He78)C080-20160331
|k C080
|l Molekulare Epidemiologie
|x 1
920 1 _ |0 I:(DE-He78)B072-20160331
|k B072
|l Molekulargenetik des Mammakarzinoms
|x 2
920 1 _ |0 I:(DE-He78)B070-20160331
|k B070
|l B070 Funktionelle Genomanalyse
|x 3
920 1 _ |0 I:(DE-He78)TU01-20160331
|k TU01
|l DKTK Koordinierungsstelle Tübingen
|x 4
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)C020-20160331
980 _ _ |a I:(DE-He78)C080-20160331
980 _ _ |a I:(DE-He78)B072-20160331
980 _ _ |a I:(DE-He78)B070-20160331
980 _ _ |a I:(DE-He78)TU01-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21